Venlafaxine and atenolol disrupt epinephrine-stimulated glucose production in rainbow trout hepatocytes

Aquatic Toxicology

Volumn 106-107, Issue , 2012, Pages 48-55

  Ings, J S ^a   George, N ^b   Peter, M C S ^b   Servos, M R ^a   Vijayan, M M ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF KERALA   (India)

Author keywords

Adrenoceptor signaling; Beta blocker; Cortisol; Environmental pharmaceuticals; SSNRI; Stress response

Indexed keywords

8 BROMO CYCLIC AMP; ADRENALIN; ATENOLOL; BETA ADRENERGIC RECEPTOR; GLUCAGON; GLUCOSE; GLUCOSE TRANSPORTER 2; HYDROCORTISONE; MESSENGER RNA; VENLAFAXINE;

BIOACCUMULATION; DRUG; EFFLUENT; FISH; GLUCOSE; INHIBITION; PHYSIOLOGICAL RESPONSE; POLLUTION EXPOSURE; RNA; SIGNALING; WASTEWATER;

ACUTE STRESS; ANIMAL CELL; ARTICLE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLUCONEOGENESIS; IN VITRO STUDY; INHIBITION KINETICS; LIVER; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAINBOW TROUT; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; ATENOLOL; CYCLOHEXANOLS; EPINEPHRINE; GLUCOSE; HEPATOCYTES; HYDROCORTISONE; ONCORHYNCHUS MYKISS; SEROTONIN UPTAKE INHIBITORS; WATER POLLUTANTS, CHEMICAL;

ANIMALIA; ONCORHYNCHUS MYKISS; SALMONIDAE;

EID: 80155140392     PISSN: 0166445X     EISSN: 18791514     Source Type: Journal    
DOI: 10.1016/j.aquatox.2011.10.006     Document Type: Article

References (52)

1. Alder A.C., Schaffner C., Majewsky M., Klasmeier J., Fenner K. Fate of b-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland. Water Res. 2010, 44:936-948.
2. Aluru N., Vijayan M.M. Hepatic transcriptome response to glucocorticoid receptor activation in rainbow trout. Physiol. Genomics 2007, 31:483-491.
3. Bartram A.E., Winter M.J., Huggett D.B., McCormack P., Constantine L.A., Hetheridge M.J., Hutchinson T.H., Kinter L.B., Ericson J.F., Sumpter J.P., Owen S.F. In vivo and in vitro liver and gill EROD activity in rainbow trout (Oncorhynchus mykiss) exposed to the beta-blocker propranolol. Environ. Toxicol. 2011, 10.1002/tox.20684.
4. Baker G.B., Greenshaw A.J. Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell. Mol. Neurobiol. 1989, 9(1):1-44.
5. Corcoran J., Winter M.J., Tyler C.R. Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish. Crit. Rev. Toxicol. 2010, 40:287-304.
6. Dugan S.G., Chen X., Nickerson J.G., Montpetit C.J., Moon T.W. Regulation of the black bullhead hepatic beta-adrenoceptors. Comp. Biochem. Physiol. B 2008, 149:265-274.
7. Fabbri E., Selva C., Moon T.W., Capuzzo A. Characterization of [3H]CGP 12177 binding to beta-adrenergic receptors in intact eel hepatocytes. Gen. Comp. Endocrinol. 2001, 121(3):223-231.
8. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
9. Giltrow E., Eccles P.D., Winter M.J., McCormack P.J., Rand-Weaver M., Hutchinson T.H., Sumpter J.P. Chronic effects assessment and plasma concentrations of the beta-blocker propranolol in fathead minnows (Pimephales promelas). Aquat. Toxicol. 2009, 95(3):195-202.
10. Hampel M., Alonso E., Aparicio I., Bron J.E., Santos J.L., Taggart J.B., Leaver M.J. Potential physiological effects of pharmaceutical compounds in Atlantic salmon (Salmo salar) implied by transcriptomic analysis. Environ. Sci. Pollut. Res. Int. 2010, 17(4):917-933.
11. IMS Health Commonly Requested Therapeutic Class and Product Information 2006, IMS Health, Inc. http://www.imshealth.com/ims/portalfromt/articleC/0,2777,65991873177056778,00.html.
12. Ings, J.S., 2011. Stress and Metabolic Responses to Municipal Wastewater Effluent Exposure in Rainbow Trout. Ph.D. Thesis, University of Waterloo.
13. Ings J.S., Servos M.R., Vijayan M.M. Hepatic transcriptomics and protein expression in rainbow trout exposed to municipal wastewater effluent. Environ. Sci. Technol. 2011, 45(6):2368-2376.
14. Ings J.S., Servos M.R., Vijayan M.M. Chronic exposure to municipal wastewater effluent affects stress performance in rainbow trout. Aquat. Toxicol. 2011, 103(1-2):85-91.
15. Iwama G.K., Alfonso L.O.B., Vijayan M.M. Stress in fish. The Physiology of Fishes 2006, 319-342. CRC Press, Boca Raton. 3rd ed. D.H. Evans, J.B. Clairborne (Eds.).
16. Knacker T., Metcalfe C. Introduction to the special issue on environmental risk assessment of pharmaceuticals. Integr. Environ. Assess. Manage. 2010, 6(Suppl.):511-513.
17. Kreke N., Dietrich D.R. Physiological endpoints for potential SSRI interactions in fish. Crit. Rev. Toxicol. 2008, 37:215-247.
18. Küster A., Alder A.C., Escher B.I., Duis K., Fenner K., Garric J., Hutchinson T.H., Lapen D.R., Péry A., Römbke J., Snape J., Ternes T., Topp E., Wehrhan A., Knacker T. Environmental risk assessment of human pharmaceuticals in the European Union: a case study with the β-blocker atenolol. Integr. Environ. Assess. Manage. 2010, 6(Suppl.):514-523.
19. Lam D.D., Heisler L.K. Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes. Expert Rev. Mol. Med. 2007, 9(5):1-24.
20. Lister A., Regan C., Van Zwol J., Van der Kraak G. Inhibition of egg production in zebrafish by fluoxetine and municipal effluents: a mechanistic evaluation. Aquat. Toxicol. 2009, 95:320-329.
21. Massarsky A., Trudeau V.L., Moon T.W. β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms. J. Exp. Zool. A: Ecol. Genet. Physiol. 2011, 315(5):251-265.
22. McIntyre R.S., Soczynska J.K., Konarski J.Z., Kennedy S.H. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin. Drug Saf. 2006, 5(1):157-168.
23. Mendonça P.C., Gamperl A.K. Nervous and humoral control of cardiac performance in the winter flounder (Pleuronectes americanus). J. Exp. Biol. 2009, 212(7):934-944.
24. Mennigen J.A., Martyniuk C.J., Crump K., Xiong H., Zhao E., Popesku J., Anisman H., Cossins A.R., Xia X., Trudeau V.L. Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). Physiol. Genomics 2008, 35:273-282.
25. Mennigen J.A., Harris E.A., Chang J.P., Moon T.W., Trudeau V.L. Fluoxetine affects weight gain and expression of feeding peptides in the female goldfish. Brain Regul. Peptides 2009, 155:99-104.
26. Mennigen J.A., Sassine J., Trudeau V.L., Moon T.W. Waterborne fluoxetine disrupts feeding and energy metabolism in the goldfish Carassius auratus. Aquat. Toxicol. 2010, 100(1):128-137.
27. Mennigen J.A., Lado W.E., Zamora J.M., Duarte-Guterman P., Langlois V.S., Metcalfe C.D., Chang J.P., Moon T.W., Trudeau V.L. Waterborne fluoxetine disrupts the reproductive axis in sexually mature male goldfish, Carassius auratus. Aquat. Toxicol. 2010, 100(4):354-364.
28. Metcalfe C.D., Koenig B.G., Bennie D.T., Servos M., Ternes T.A., Hirsch R. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ. Toxicol. Chem. 2003, 22:2872-2880.
29. Metcalfe C.D., Chu S., Judt C., Li H., Oakes K.D., Servos M.R., Andrews D.M. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ. Toxicol. Chem. 2010, 29:79-89.
30. Miura T., Kato M., Iwamoto N., Yamada Y., Ishida T., Seino Y., Tanigawa K. Effect of epinephrine on GLUT2 protein content in mouse liver. Biol. Pharm. Bull. 2000, 23(11):1374-1376.
31. Mommsen T.P., Moon T.W. Metabolic response of teleost hepatocytes to glucagon-like peptide and glucagon. J. Endocrinol. 1990, 126:109-118.
32. Mommsen T.P., Vijayan M.M., Moon T.W. Cortisol in teleosts: dynamics, mechanism s of action, and metabolic regulation. Rev. Fish Biol. Fish. 1999, 9:211-268.
33. Moon T.W., Walsh P.J., Mommsen T.P. Fish hepatocytes-a model metabolic system. Can. J. Fish. Aquat. Sci. 1985, 42:1772-1782.
34. Navarro I., Leibush B., Moon T.W., Plisetskaya E.M., Baños N., Méndez E., Planas J.V., Gutiérrez J. Insulin, insulin-like growth factor-I (IGF-I) and glucagon: the evolution of their receptors. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 1999, 122(2):137-153.
35. Nickerson J.G., Dugan S.G., Drouin G., Moon T.W. A putative beta2-adrenoceptor from the rainbow trout (Oncorhynchus mykiss). Molecualr characterization and pharmacology. Eur. J. Biochem. 2001, 268:6465-6472.
36. Oakes K.D., Coors A., Escher B., Fenner K., Garric J., Gus t.M., Knacker T., Kuster A., Kussatz C., Metcalfe C.D., Monteiro S., Moon T., Mennigen J.A., Parrott J., Pery A.R., Ramil M., Tarazona J.V., Sanchez-Arguello P., Ternes T.A., Trudeau V.L., Boucard T., Van der Kraak G.J., Servos M. An environmental risk assessment for the serotonin reuptake inhibitor fluoxetine-a case study utilizing the European risk assessment framework. Integr. Environ. Assess. Manage. 2010, 6(Suppl.):1-16.
37. Owen S.F., Giltrow E., Huggett D.B., Hutchinson T.H., Saye J., Winter M.J., Sumpter J.P. Comparative physiology, pharmacology and toxicology of β-blockers in fish: a critical review. Aquat. Toxicol. 2007, 82:145-162.
38. Owen S.F., Huggett D.B., Hutchinson T.H., Hetheridge M.J., Kinter L.B., Ericson J.F., Sumpter J.P. Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry. Aquat. Toxicol. 2009, 93(4):217-224.
39. Rang H.P., Dale M.M., Ritter J.M., Moore P.K. Pharmacology 2003, Elsevier, Churchill Livingstone, p. 797. 5th ed.
40. Reid S.G., Bernier N.J., Perry S.F. The adrenergic stress response in fish: control of catecholamine storage and release. Comp. Biochem. Physiol. C 1998, 120:1-27.
41. Richardson S.D. Water analysis: emerging contaminants and current issues. Anal. Chem. 2009, 81:4645-4677.
42. Sandhu N., Vijayan M.M. Cadmium-mediated disruption of cortisol biosynthesis involves suppression of corticosteroidogenic genes in rainbow trout. Aquat. Toxicol. 2011, 103(1-2):92-100.
43. Sathiyaa R., Campbell T., Vijayan M.M. Cortisol modulates HSP90 mRNA expression in primary cultures of trout hepatocytes. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 2001, 129(2-3):679-685.
44. Schaan B.D., Irigoyen M.C., Lacchini S., Moreira E.D., Schmid H., Machado U.F. Sympathetic modulation of the renal glucose transporter GLUT2 in diabetic rats. Auton. Neurosci. 2005, 117(1):54-61.
45. Servos M.R., Smith M., McInnis R., Burnison K., Lee B.-H., Seto P., Backus S. Presence and removal of acidic drugs in drinking water in Ontario, Canada. Water Qual. Res. J. Can. 2007, 42:130-137.
46. van den Thillart G., Vianen G., Ponce M.C., Lelieveld H., Nieveen M., Van Raaij M., Steffens A., Zaagsma J. Differential role of adrenoceptors in control of plasma glucose and fatty acids in carp, Cyprinus carpio (L.). Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281(2):R615-R624.
47. Vijayan M.M., Reddy P.K., Leatherland J.F., Moon T.W. The effects of cortisol on hepatocyte metabolism in rainbow trout: a study using the steroid analogue RU486. Gen. Comp. Endocrinol. 1994, 96(1):75-84.
48. Vijayan M.M., Raptis S., Sathiyaa R. Cortisol treatment affects glucocorticoid receptor and glucocorticoid-responsive genes in the liver of rainbow trout. Gen. Comp. Endocrinol. 2003, 132(2):256-263.
49. Weber J.M., Shanghavi D.S. Regulation of glucose production in rainbow trout: role of epinephrine in vivo and in isolated hepatocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278(4):R956-R963.
50. Wendelaar Bonga S.E. The stress response in fish. Physiol. Rev. 1997, 77:591-625.
51. Wick A., Fink G., Joss A., Siegrist H., Ternes T.A. Fate of beta blockers and psycho-active drugs in conventional wastewater treatment. Water Res. 2009, 43(4):1060-1074.
52. Winter M.J., Lillicrap A.D., Caunter J.E., Schaffner C., Alder A.C., Ramil M., Ternes T.A., Giltrow E., Sumpter J.P., Hutchinson T.H. Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas). Aquat. Toxicol. 2008, 86(3):361-369.